3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Motor Activity
126
Breast Neoplasms
78
Neoplasms
48
Prostatic Neoplasms
19
Fatigue
16
Obesity
14
Colorectal Neoplasms
13
Lung Neoplasms
11
Polycystic Ovary Syndrome
10
Colonic Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Head and Neck Neoplasms
7
Weight Loss
6
Ovarian Neoplasms
6
Rectal Neoplasms
5
Multiple Myeloma
5
Lymphedema
5
Leukemia
5
Inflammation
5
Pancreatic Neoplasms
4
Overweight
4
Multiple Endocrine Neoplasia Type 1
4
Lymphoma
4
Leukemia, Myeloid, Acute
4
Insulin Resistance
4
Depression
4
Cognitive Dysfunction
4
Brain Neoplasms
4
Stomach Neoplasms
3
Peripheral Nervous System Diseases
3
Interventions
entinostat
3
Carboplatin
3
Pemetrexed
2
Bronchoscopy
2
sotorasib
1
pralsetinib
1
pembrolizumab
1
osimertinib
1
lorlatinib
1
ficlatuzumab
1
exemestane
1
demcizumab
1
cobimetinib
1
camrelizumab
1
aflibercept
1
Tyrosine Kinase Inhibitors
1
Thrombin
1
Temozolomide
1
TachoSil
1
Saline Solution
1
Radiomics
1
Paclitaxel
1
One-Lung Ventilation
1
Nutritional Status
1
Microscopy, Confocal
1
Gefitinib
1
Fibrinogen
1
Exercise
1
Erlotinib Hydrochloride
1
Diagnostic Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Lung Diseases
×
Exercise
×
Clear all
NCT04666558
2022-10-04
PiONEeR
University of Alberta
Phase NA
Completed
216 enrolled